Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Survival Analysis (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Surveys and Questionnaires (statistics & numerical data) < Survival Analysis (MeSH) < Survival Rate (MeSH)  Facettes :

List of bibliographic references indexed by Survival Analysis (MeSH)

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000352 (2021) Nicolas De Schryver [Belgique] ; Nicolas Serck [Belgique] ; Marco Vinetti [Belgique] ; Ludovic Gérard [Belgique]Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
000389 (2021) Nirvana Awad [États-Unis] ; Daryl S. Schiller [États-Unis] ; Magda Fulman [États-Unis] ; Azfar Chak [États-Unis]Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection.
000518 (2021) Michele Bartoletti [Italie] ; Lorenzo Marconi [Italie] ; Luigia Scudeller [Italie] ; Livia Pancaldi [Italie] ; Sara Tedeschi [Italie] ; Maddalena Giannella [Italie] ; Matteo Rinaldi [Italie] ; Linda Bussini [Italie] ; Ilaria Valentini [Italie] ; Anna Filomena Ferravante [Italie] ; Antonella Potalivo [Italie] ; Elisa Marchionni [Italie] ; Giacomo Fornaro [Italie] ; Renato Pascale [Italie] ; Zeno Pasquini [Italie] ; Massimo Puoti [Italie] ; Marco Merli [Italie] ; Francesco Barchiesi [Italie] ; Francesca Volpato [Italie] ; Arianna Rubin [Italie] ; Annalisa Saracino [Italie] ; Tommaso Tonetti [Italie] ; Paolo Gaibani [Italie] ; Vito Marco Ranieri [Italie] ; Pierluigi Viale [Italie] ; Francesco Cristini [Italie]Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
000536 (2021) Thibault Fiolet [France] ; Anthony Guihur [Suisse] ; Mathieu Edouard Rebeaud [Suisse] ; Matthieu Mulot [Suisse] ; Nathan Peiffer-Smadja [France] ; Yahya Mahamat-Saleh [France]Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
000542 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
000583 (2021) Khalid Changal [États-Unis] ; David Paternite [États-Unis] ; Sean Mack [États-Unis] ; Spiro Veria [États-Unis] ; Rehana Bashir [États-Unis] ; Mitra Patel [États-Unis] ; Ronak Soni [États-Unis] ; Muhammad Ali [États-Unis] ; Tanveer Mir [États-Unis] ; Mujeeb Sheikh [États-Unis] ; P Kasi Ramanathan [États-Unis]Coronavirus disease 2019 (COVID-19) and QTc prolongation.
000757 (2021) Michael Ewers [Allemagne] ; John P A. Ioannidis [États-Unis] ; Nikolaus Plesnila [Allemagne]Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive.
000B14 (2020) Sarah Micallef [Malte] ; Tonio V. Piscopo [Malte] ; Ramon Casha [Malte] ; Denise Borg [Malte] ; Chantal Vella [Malte] ; Maria-Alessandra Zammit [Malte] ; Janice Borg [Malte] ; Daniela Mallia [Malte] ; James Farrugia [Malte] ; Sarah Marie Vella [Malte] ; Thelma Xerri [Malte] ; Anette Portelli [Malte] ; Manuel Fenech [Malte] ; Claudia Fsadni [Malte] ; Charles Mallia Azzopardi [Malte]The first wave of COVID-19 in Malta; a national cross-sectional study.
000C42 (2020) Ehsan Sekhavati [Iran] ; Fatemeh Jafari [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Saeidreza Jamalimoghadamsiahkali [Iran] ; Sara Sadr [Iran] ; Mohammad Tabarestani [Iran] ; Mohammad Pirhayati [Iran] ; Abolfazl Zendehdel [Iran] ; Navid Manafi [Iran] ; Mahboubeh Hajiabdolbaghi [Iran] ; Zahra Ahmadinejad [Iran] ; Hamid Emadi Kouchak [Iran] ; Sirous Jafari [Iran] ; Hosein Khalili [Iran] ; Mohamadreza Salehi [Iran] ; Arash Seifi [Iran] ; Fereshteh Shahmari Golestan [Iran] ; Fereshteh Ghiasvand [Iran]Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.
000E24 (2020) Anne Lohse [France] ; Timothée Klopfenstein [France] ; Jean-Charles Balblanc [France] ; Pierre-Yves Royer [France] ; Marie Bossert [France] ; Vincent Gendrin [France] ; Aline Charpentier [France] ; Ana-Maria Bozgan [France] ; Julio Badie [France] ; Charlotte Bourgoin [France] ; Remy Contreras [France] ; Isabelle Mazurier [France] ; Thierry Conrozier [France] ; Souheil Zayet [France]Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
001041 (2020) Lorenzo M. Canziani [Italie] ; Serena Trovati [Italie] ; Enrico Brunetta [Italie] ; Amidio Testa [Italie] ; Maria De Santis [Italie] ; Emilio Bombardieri [Italie] ; Giacomo Guidelli [Italie] ; Giovanni Albano [Italie] ; Marco Folci [Italie] ; Michela Squadroni [Italie] ; Giordano D. Beretta [Italie] ; Michele Ciccarelli [Italie] ; Massimo Castoldi [Italie] ; Ana Lleo [Italie] ; Alessio Aghemo [Italie] ; Laura Vernile [Italie] ; Alberto Malesci [Italie] ; Paolo Omodei [Italie] ; Claudio Angelini [Italie] ; Salvatore Badalamenti [Italie] ; Maurizio Cecconi [Italie] ; Alberto Cremonesi [Italie] ; Carlo Selmi [Italie]Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.
001091 (2020) Benjamin Davido [France] ; Ghilas Boussaid [France] ; Isabelle Vaugier [France] ; Thibaud Lansaman [France] ; Frédérique Bouchand [France] ; Christine Lawrence [France] ; Jean-Claude Alvarez [France] ; Pierre Moine [France] ; Véronique Perronne [France] ; Frédéric Barbot [France] ; Azzam Saleh-Mghir [France] ; Christian Perronne [France] ; Djillali Annane [France] ; Pierre De Truchis [France]Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.
001166 (2020) Sherief Abd-Elsalam [Égypte] ; Eslam Saber Esmail [Égypte] ; Mai Khalaf [Égypte] ; Ehab Fawzy Abdo [Égypte] ; Mohammed A. Medhat [Égypte] ; Mohamed Samir Abd El Ghafar [Égypte] ; Ossama Ashraf Ahmed [Égypte] ; Shaimaa Soliman [Égypte] ; Ghada N. Serangawy [Égypte] ; Mohamed Alboraie [Égypte]Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
001327 (2020) Qing Ye [République populaire de Chine] ; Bili Wang [République populaire de Chine] ; Jianhua Mao [République populaire de Chine] ; Junfen Fu [République populaire de Chine] ; Shiqiang Shang [République populaire de Chine] ; Qiang Shu [République populaire de Chine] ; Ting Zhang [République populaire de Chine]Epidemiological analysis of COVID-19 and practical experience from China.
001348 (2020) Shubham Misra [Inde] ; Manabesh Nath [Inde] ; Vijay Hadda [Inde] ; Deepti Vibha [Inde]Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
001370 (2020) Catia Marzolini [Suisse] ; Felix Stader [Suisse] ; Marcel Stoeckle [Suisse] ; Fabian Franzeck [Suisse] ; Adrian Egli [Suisse] ; Stefano Bassetti [Suisse] ; Alexa Hollinger [Suisse] ; Michael Osthoff [Suisse] ; Maja Weisser [Suisse] ; Caroline E. Gebhard [Suisse] ; Veronika Baettig [Suisse] ; Julia Geenen [Suisse] ; Nina Khanna [Suisse] ; Sarah Tschudin-Sutter [Suisse] ; Daniel Mueller [Suisse] ; Hans H. Hirsch [Suisse] ; Manuel Battegay [Suisse] ; Parham Sendi [Suisse]Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
001586 (2020) Miguel Angel Martinez [Espagne]Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
001618 (2020) Mohammad Sultan Khuroo [Inde]Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
001825 (2020) Tycho Baumann [Espagne] ; Julio Delgado [Espagne] ; Emili Montserrat [Espagne]CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report.
001886 (2020) Chang Li [République populaire de Chine] ; Lin Wang [République populaire de Chine] ; Linzhu Ren [République populaire de Chine]Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Survival Analysis (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Survival Analysis (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Survival Analysis (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021